FDAnews Drug Daily Bulletin
Oct. 11, 2012 | Vol. 9 No. 200
Pharma Blog Watch
Say What? Inception Inks Hearing-Loss Deal With Roche (The In Vivo Blog)
Inception Sciences in an “unusual manner” Wednesday revealed its first pharma partner, Roche, blogger Alex Lash writes. “The San Diego firm has created a spin-off dubbed Inception 3 that will house a technology platform from Stanford University and develop drugs to treat permanent hearing loss,” Lash adds. The announcement came by way of an “advertorial,” penned by Roche, touting its neurology partnering program in the Oct. 10 issue of Nature, Lash writes
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.